Oceana Therapeutics Corporate Overview
Redefining Specialty Treatment and Physician Care Management to
Achieve Optimal Wellness
Headquartered in Edison, NJ, Oceana Therapeutics was founded specifically to serve the needs of the specialty pharmaceuticals market, extending its established resources and extensive capabilities to set new standards for specialty pharmaceuticals worldwide. An industry pioneer, Oceana Therapeutics delivers a unique Optimal Outcomes strategy of identifying, acquiring and maximizing the potential of approved and late-stage development specialty pharmaceuticals-- redefining the way illnesses are treated.
Oceana Therapeutics’ goal is to enable physicians to prescribe drugs and deliver dosages that are specifically tailored for the patient’s disease — offering Optimal Outcomes— whether by decreasing “pill burden”, timing dosage release to optimize efficacy or offering the added economic benefit of limiting or eliminating hospitalization, reducing demand for surgery or emergency care.
This approach balances both the patient’s wellness needs and the physician’s requirements to provide outstanding patient care while efficiently balancing time and economic management constraints.
Oceana Therapeutics is set to be one of the world’s leading specialty pharmaceutical companies, with an unrivaled leadership team who collectively offer over 200 years in specialty pharmaceutical sales and development. As the most tested leadership team in the Industry, Oceana Therapeutics offers the unique difference of its entire management team having worked together previously, leaving to successfully form new specialty companies and now rejoining to collaborate to acquire under-valued drugs, develop new drugs, drive sales, and build product value.
Oceana Therapeutics’ management is dedicated to the concept of Optimal Outcomes for all participants in the management of disease; patients, doctors, health insurance plans and distributors. From years of hard won experience, we recognize that a failure to execute perfectly in any one of these areas will result in difficulty for all. By planning and assuring all participants are, accounted for, Oceana Therapeutics is poised to deliver Optimal Outcomes for patients, physicians, insurance plans, and distributors.
- Specialty Treatment Redefined
Oceana Therapeutics redefines the way illnesses are treated by packaging wellness options that uniquely balance care management constraints such as time efficiencies, patient affordability and healthcare and governmental payer issues -- not just manufacturer requirements.
- Physician/Health Professional Care Management Redefined
Oceana Therapeutics’ goal is to redefine limitations and allow physicians and heath providers to deliver treatments that are specifically tailored for each patient— whether by reducing pain, increasing mobility, improving quality of life or offering the added economic benefit by limiting or eliminating hospitalization, reducing demand for surgery or emergency care.
- Patient Care Redefined
Oceana Therapeutics’ is ideally positioned to redefine a new patient optimal wellness paradigm that addresses more appropriate ways to manage the handling and service requirements of specialty pharmaceuticals, including dispensing, distribution, reimbursement, case management, and other services specific to a patients’ way of life.
“Specialty pharmaceuticals represent the fastest growing segment of the prescription drug market in the United States, with a projected 20% annual growth rate. Typically, these products are high cost. It is anticipated that by 2008, the specialty pharmacy component will be >20% of all drug costs, reaching about $73 billion in total dollars. With monthly per patient costs averaging $1000 to $1500, payers (the government, private employers, and managed care organizations) are focusing on ways to effectively manage use of these drugs to realize treatment potential, but at a lowered cost that still ensures patients appropriate access.”
National Association of Chain Drug Stores.
© 2008 Pharmacy Times |
|
